Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Ding

Showing results (601-610 of 736) with videos related to

Pageof 74
Sort By:
World Journal of Gastrointestinal Oncology|January 16, 2025
Predictive value of a constructed artificial neural network model for microvascular invasion in hepatocellular carcinoma: A retrospective studyHai-Yang Nong, Yong-Yi Cen, Shan-Jin Lu, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFR<sup>T790M/C797S</sup> MutantsShan Li, Tao Zhang, Su-Jie Zhu, et al.
Radiation and Environmental Biophysics|February 25, 2009
Induced expression of the IER5 gene by gamma-ray irradiation and its involvement in cell cycle checkpoint control and survivalKu-Ke Ding, Zeng-Fu Shang, Chuan Hao, et al.
Frontiers in Pharmacology|February 2, 2026
Serine synthesis and transport mediate the synergistic and detoxifying effects of lienal peptides on cisplatinKe Ding, Tengjie Yu, Xiaowei Zhang, et al.
Journal of Hepatology|November 22, 2025
MARCO<sup>+</sup> macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitisKe Ding, Anrong Mao, Yong Wang, et al.
Journal of Medicinal Chemistry|October 8, 2021
Novel Electrophilic Warhead Targeting a Triple-Negative Breast Cancer Driver in Live Cells Revealed by "Inverse Drug Discovery"Youlong Fan, Hongfei Si, Zhang Zhang, et al.
The Lancet Regional Health. Western Pacific|July 1, 2024
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trialXiang Yan, Jianhua Ma, Yan Liu, et al.
Journal of Affective Disorders|January 29, 2026
Biological age acceleration associated with mental and behavioural disorders: Evidence from the UK biobank cohortZixi Zhu, Hoiyin Cheung, Ke Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2023
Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic FunctionsTangming Guan, Mei Li, Yan Song, et al.
Journal of Medicinal Chemistry|July 13, 2019
Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR<sup>L858R/T790M/C797S</sup>)Jiayi Shen, Tao Zhang, Su-Jie Zhu, et al.
Pageof 74

Showing results (601-610 of 736) with videos related to

Sort By:
Pageof 74
World Journal of Gastrointestinal Oncology|January 16, 2025
Predictive value of a constructed artificial neural network model for microvascular invasion in hepatocellular carcinoma: A retrospective studyHai-Yang Nong, Yong-Yi Cen, Shan-Jin Lu, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFR<sup>T790M/C797S</sup> MutantsShan Li, Tao Zhang, Su-Jie Zhu, et al.
Radiation and Environmental Biophysics|February 25, 2009
Induced expression of the IER5 gene by gamma-ray irradiation and its involvement in cell cycle checkpoint control and survivalKu-Ke Ding, Zeng-Fu Shang, Chuan Hao, et al.
Frontiers in Pharmacology|February 2, 2026
Serine synthesis and transport mediate the synergistic and detoxifying effects of lienal peptides on cisplatinKe Ding, Tengjie Yu, Xiaowei Zhang, et al.
Journal of Hepatology|November 22, 2025
MARCO<sup>+</sup> macrophages drive immunosuppressive remodeling and metastasis in chemotherapy-associated steatohepatitisKe Ding, Anrong Mao, Yong Wang, et al.
Journal of Medicinal Chemistry|October 8, 2021
Novel Electrophilic Warhead Targeting a Triple-Negative Breast Cancer Driver in Live Cells Revealed by "Inverse Drug Discovery"Youlong Fan, Hongfei Si, Zhang Zhang, et al.
The Lancet Regional Health. Western Pacific|July 1, 2024
Efficacy and safety of visepegenatide, a long-acting weekly GLP-1 receptor agonist as monotherapy in type 2 diabetes mellitus: a randomised, double-blind, parallel, placebo-controlled phase 3 trialXiang Yan, Jianhua Ma, Yan Liu, et al.
Journal of Affective Disorders|January 29, 2026
Biological age acceleration associated with mental and behavioural disorders: Evidence from the UK biobank cohortZixi Zhu, Hoiyin Cheung, Ke Ding, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 14, 2023
Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic FunctionsTangming Guan, Mei Li, Yan Song, et al.
Journal of Medicinal Chemistry|July 13, 2019
Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR<sup>L858R/T790M/C797S</sup>)Jiayi Shen, Tao Zhang, Su-Jie Zhu, et al.
Pageof 74